Evidence map›Paper›PMID 39287702›Full record

ArticleClinical rheumatology2024

Anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis with liver dysfunction: a warning sign of higher death risk.

Wanxing Mo, Xiaoyan Xing, Suhong Zhai, Meixia Peng, Luqi Wang, Jian Zhang, Chenglong Shi, Jingtian Li, Dan Lu, Yuhui Li and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Wanxing MoDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
Xiaoyan XingDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
Suhong ZhaiDepartment of Geriatry, Rheumatology and Immunology, the Eighth People's Hospital of Hengshui, Hengshui, China.
Meixia PengDepartment of Rheumatology and Immunology, Shijiazhuang People's Hospital, Shijiazhuang, China.
Luqi WangDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
Jian ZhangDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
Chenglong ShiDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
Jingtian LiDepartment of Orthopedics and Trauma, Peking University People's Hospital, Beijing, China.
Dan LuInstitute of Systems Biomedicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China. taotao@bjmu.edu.cn.
Yuhui LiDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China. liyuhui84@163.com.
Jing HeDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China. hejing1105@126.com.

Funding

Beijing Natural Science Foundation-Haidian Original Innovation Joint Fund L222017
6 · The paper itself

Abstract

This study aimed to investigate and analyze the clinical and immunological features of patients with anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis (MDA5

Indexed as

AutoantibodiesDermatomyositisInterferon-Induced Helicase, IFIH1Liver DiseasesAdultAgedFemaleHumansMaleMiddle AgedPrognosisRetrospective StudiesRisk FactorsAutoantibodiesIFIH1 protein, humanInterferon-Induced Helicase, IFIH1Anti-melanoma differentiation-associated gene-5 antibodyDermatomyositisLiver dysfunctionPrognosis

Identifiers

PMID39287702

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.